Lantheus Inc.

NASDAQ: LNTH · Real-Time Price · USD
77.19
1.63 (2.16%)
At close: Jun 02, 2025, 3:59 PM
77.13
-0.07%
After-hours: Jun 02, 2025, 07:47 PM EDT

Lantheus Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
DEFINITY Revenue 317.79M 279.77M 244.99M 232.76M 183.07M 157.27M 131.61M 72.56M
DEFINITY Revenue Growth +13.59% +14.19% +5.26% +27.14% +16.41% +19.49% +81.38% n/a
License and Royalty Revenues Revenue 9.13M 33.36M 48.02M 24.85M 98.86M 104.64M 99.22M n/a
License and Royalty Revenues Revenue Growth -72.64% -30.53% +93.24% -74.86% -5.53% +5.47% n/a n/a
Other Precision Diagnostics Revenue 24.23M 22.98M 22.82M 26.97M n/a n/a n/a n/a
Other Precision Diagnostics Revenue Growth +5.44% +0.68% -15.38% n/a n/a n/a n/a n/a
Other Radiopharmaceutical Oncology Revenue 384K 3.13M 4.1M 5.47M n/a n/a n/a n/a
Other Radiopharmaceutical Oncology Revenue Growth -87.73% -23.70% -25.05% n/a n/a n/a n/a n/a
PYLARIFY Revenue 1.06B 851.3M 527.4M 43.41M n/a n/a n/a n/a
PYLARIFY Revenue Growth +24.26% +61.41% +1114.83% n/a n/a n/a n/a n/a
Product Revenue 1.52B 1.26B 531.51M 48.89M n/a n/a n/a n/a
Product Revenue Growth +20.72% +137.64% +987.22% n/a n/a n/a n/a n/a
Radiopharmaceutical Oncology Revenue 1.06B 854.43M 46.87M 25.3M n/a n/a n/a n/a
Radiopharmaceutical Oncology Revenue Growth +23.85% +1722.91% +85.29% n/a n/a n/a n/a n/a
Strategic Partnerships And Other Revenue 38.18M 51.88M 88.86M 91.29M n/a n/a n/a n/a
Strategic Partnerships And Other Revenue Growth -26.40% -41.62% -2.66% n/a n/a n/a n/a n/a
Techne Lite Revenue 95.49M 87.37M 356.68M 351.02M n/a n/a n/a n/a
Techne Lite Revenue Growth +9.29% -75.50% +1.61% n/a n/a n/a n/a n/a
Total Precision Diagnostics Revenue 437.51M 390.12M n/a n/a n/a n/a n/a n/a
Total Precision Diagnostics Revenue Growth +12.15% n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 31, 2020 Dec 31, 2019
Us Segment Revenue 294.8M 72.53M
Us Segment Revenue Growth +306.42% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 99.32M 101.41M 84.23M 92.54M 93.44M 75.56M 73.14M 62.61M 55.89M 66.62M 49.17M 60.09M 57.94M 81.95M 45.74M 60.81M 30.31M 26.54M 29.83M 26.98M 26.83M 27.69M 28.21M 24.24M 22.99M 22.35M 24.09M 23.7M 23.18M 24.72M 22.15M 22.81M 22.48M 18.68M 18.8M 19.08M 18.82M 17.93M 17.84M 24.67M 18.2M
Selling, General, and Administrative Revenue Growth -2.06% +20.39% -8.98% -0.96% +23.67% +3.31% +16.82% +12.02% -16.11% +35.48% -18.17% +3.71% -29.30% +79.15% -24.77% +100.61% +14.20% -11.01% +10.57% +0.54% -3.12% -1.84% +16.38% +5.46% +2.84% -7.21% +1.61% +2.25% -6.20% +11.58% -2.87% +1.43% +20.39% -0.64% -1.49% +1.39% +4.98% +0.49% -27.70% +35.60% n/a
Research and Development Revenue 36.31M 35.33M 24.15M 60.6M 48.02M 16.82M 14.45M 15.9M 30.53M 272.23M 12.52M 14.73M 12.2M 11.29M 11.25M 12.06M 10.36M 12.64M 11.68M 4.42M 4.05M 4.43M 4.86M 5.79M 4.93M 4.55M 4.32M 4.21M 3.99M 3.98M 3.55M 5.24M 5.35M 3.71M 2.85M 2.61M 3.04M 3.07M 2.46M 2.64M 6.2M
Research and Development Revenue Growth +2.80% +46.29% -60.15% +26.19% +185.45% +16.43% -9.13% -47.92% -88.78% +2074.85% -15.05% +20.75% +8.06% +0.36% -6.71% +16.42% -18.03% +8.17% +164.46% +9.14% -8.71% -8.77% -16.13% +17.57% +8.31% +5.44% +2.40% +5.67% +0.33% +11.87% -32.23% -2.00% +44.23% +30.22% +9.24% -14.10% -0.98% +24.74% -6.82% -57.42% n/a
Sales and Marketing Revenue 42.5M 43.64M 43.72M 45.03M 45.55M 35.26M 37.4M 36.46M 32.62M 26.98M 25.41M 27.49M 20.35M 19.42M 17.2M 17.63M 14.17M 12.86M 11.61M 6.3M 10.13M 10.39M 10.15M 10.95M 10.4M 9.91M 10.48M 12.13M 10.64M 10.42M 10.07M 11.6M 10.21M 8.69M 8.71M 9.84M 9.31M 7.81M 8.63M 9.23M 9.07M
Sales and Marketing Revenue Growth -2.61% -0.18% -2.92% -1.12% +29.16% -5.71% +2.59% +11.77% +20.88% +6.17% -7.56% +35.07% +4.79% +12.96% -2.47% +24.40% +10.24% +10.75% +84.12% -37.76% -2.52% +2.37% -7.28% +5.30% +4.90% -5.41% -13.62% +14.00% +2.08% +3.45% -13.17% +13.60% +17.59% -0.23% -11.55% +5.76% +19.23% -9.58% -6.46% +1.73% n/a